Nothing Special   »   [go: up one dir, main page]

GB201313990D0 - Combination immunogenic compositions - Google Patents

Combination immunogenic compositions

Info

Publication number
GB201313990D0
GB201313990D0 GBGB1313990.2A GB201313990A GB201313990D0 GB 201313990 D0 GB201313990 D0 GB 201313990D0 GB 201313990 A GB201313990 A GB 201313990A GB 201313990 D0 GB201313990 D0 GB 201313990D0
Authority
GB
United Kingdom
Prior art keywords
immunogenic compositions
combination immunogenic
combination
compositions
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1313990.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB1313990.2A priority Critical patent/GB201313990D0/en
Publication of GB201313990D0 publication Critical patent/GB201313990D0/en
Priority to CN201480052743.1A priority patent/CN105555304A/en
Priority to EP18214695.1A priority patent/EP3492097A1/en
Priority to KR1020167005994A priority patent/KR20160040290A/en
Priority to PCT/EP2014/066756 priority patent/WO2015018806A1/en
Priority to BE2014/0597A priority patent/BE1022008B1/en
Priority to MX2016001695A priority patent/MX2016001695A/en
Priority to US14/910,027 priority patent/US20160193322A1/en
Priority to ARP140102924A priority patent/AR097217A1/en
Priority to CA2919773A priority patent/CA2919773A1/en
Priority to EA201690115A priority patent/EA201690115A1/en
Priority to SG11201600709TA priority patent/SG11201600709TA/en
Priority to JP2016532351A priority patent/JP6564367B2/en
Priority to EP14750176.1A priority patent/EP3030260A1/en
Priority to AU2014304545A priority patent/AU2014304545A1/en
Priority to BR112016002354A priority patent/BR112016002354A2/en
Priority to IL243778A priority patent/IL243778A0/en
Priority to JP2019088303A priority patent/JP2019163284A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB1313990.2A 2013-08-05 2013-08-05 Combination immunogenic compositions Ceased GB201313990D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GBGB1313990.2A GB201313990D0 (en) 2013-08-05 2013-08-05 Combination immunogenic compositions
BR112016002354A BR112016002354A2 (en) 2013-08-05 2014-08-04 immunogenic composition, methods to protect a baby against infection or disease and to evoke an immune response, vaccination regimen, and
ARP140102924A AR097217A1 (en) 2013-08-05 2014-08-04 IMMUNOGEN COMBINATION COMPOSITIONS
EA201690115A EA201690115A1 (en) 2013-08-05 2014-08-04 COMBINED IMMUNOGENIC COMPOSITIONS
KR1020167005994A KR20160040290A (en) 2013-08-05 2014-08-04 Combination immunogenic compositions
PCT/EP2014/066756 WO2015018806A1 (en) 2013-08-05 2014-08-04 Combination immunogenic compositions
BE2014/0597A BE1022008B1 (en) 2013-08-05 2014-08-04 COMBINED IMMUNOGENIC COMPOSITIONS
MX2016001695A MX2016001695A (en) 2013-08-05 2014-08-04 Combination immunogenic compositions.
US14/910,027 US20160193322A1 (en) 2013-08-05 2014-08-04 Combination immunogenic compositions
CN201480052743.1A CN105555304A (en) 2013-08-05 2014-08-04 Combination immunogenic compositions
CA2919773A CA2919773A1 (en) 2013-08-05 2014-08-04 Combination immunogenic compositions
EP18214695.1A EP3492097A1 (en) 2013-08-05 2014-08-04 Combination immunogenic compositions
SG11201600709TA SG11201600709TA (en) 2013-08-05 2014-08-04 Combination immunogenic compositions
JP2016532351A JP6564367B2 (en) 2013-08-05 2014-08-04 Combined immunogenic composition
EP14750176.1A EP3030260A1 (en) 2013-08-05 2014-08-04 Combination immunogenic compositions
AU2014304545A AU2014304545A1 (en) 2013-08-05 2014-08-04 Combination immunogenic compositions
IL243778A IL243778A0 (en) 2013-08-05 2016-01-25 Combination immunogenic compositions
JP2019088303A JP2019163284A (en) 2013-08-05 2019-05-08 Combination immunogenic compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1313990.2A GB201313990D0 (en) 2013-08-05 2013-08-05 Combination immunogenic compositions

Publications (1)

Publication Number Publication Date
GB201313990D0 true GB201313990D0 (en) 2013-09-18

Family

ID=49224176

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1313990.2A Ceased GB201313990D0 (en) 2013-08-05 2013-08-05 Combination immunogenic compositions

Country Status (2)

Country Link
AR (1) AR097217A1 (en)
GB (1) GB201313990D0 (en)

Also Published As

Publication number Publication date
AR097217A1 (en) 2016-02-24

Similar Documents

Publication Publication Date Title
IL274024A (en) Oral compositions
IL279395A (en) Vaccine composition
GB201304662D0 (en) Compositions
EP3065716C0 (en) Formulations
EP2889350A4 (en) Tacky-adhesive composition
GB201321242D0 (en) Immunogenic compound
GB201608461D0 (en) Compositions
EP3006525A4 (en) Asphalt-urethane composition
GB201319792D0 (en) Formulations
GB201318489D0 (en) Composition
IL243778A0 (en) Combination immunogenic compositions
GB201317388D0 (en) Composition
HK1214951A1 (en) Ophthalimic formulations
GB201306984D0 (en) Composition
EP3066178A4 (en) Lumbricant composition
ZA201505650B (en) New compositions
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
GB201316463D0 (en) Novel compositions
GB201320962D0 (en) Compositions
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201318394D0 (en) Composition
GB201305622D0 (en) Composition
ZA201507770B (en) Composition with reduced immunogenicity

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)